Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 3:25 AM UTC
| NCT Number | NCT05972135 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 75 participants |
| Active Locations | 16 sites in the US |
| Sponsor | SCRI Development Innovations, LLC |
| Last Updated on CT.gov | February 23, 2026 (Feb 23, 2026) |
As of April 17, 2026: Clinical trial NCT05972135 is currently recruiting participants. This clinical trial study for multiple myeloma is actively seeking new participants at 16 locations across the United States. The study is sponsored by SCRI Development Innovations, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05972135 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05972135 was last updated Feb 23, 2026 (February 23, 2026). HelloStudys verifies this status automatically.